Previous 10 | Next 10 |
The following slide deck was published by ICU Medical, Inc. in conjunction with their 2022 Q3 earnings call. For further details see: ICU Medical, Inc. 2022 Q3 - Results - Earnings Call Presentation
ICU Medical, Inc. (ICUI) Q3 2022 Earnings Conference Call November 07, 2022, 17:00 ET Company Participants John Mills - ICR Vivek Jain - CEO & Chairman Brian Bonnell - CFO & Treasurer Conference Call Participants Jayson Bedford - Raymond James...
ICU Medical press release ( NASDAQ: ICUI ): Q3 Non-GAAP EPS of $1.75. Revenue of $597.9M (+77.9% Y/Y). FY22 adjusted diluted earnings per share is expected to be in the range of $6.20 to $6.80. For further details see: ICU Medical Non-GAAP EPS of $1.75, reven...
SAN CLEMENTE, Calif., Nov. 07, 2022 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced financial results for the quarter ended September 30, 2022. Third Quarter 2022 Results Third...
ICU Medical ( NASDAQ: ICUI ) is scheduled to announce Q3 earnings results on Monday, November 7th, after market close. The consensus EPS Estimate is $1.46 (-29.5% Y/Y) and the consensus Revenue Estimate is $569.17M (+69.3% Y/Y). Over the last 2 years, ICUI has beaten...
The U.S. Food and Drug Administration (FDA) warned on Monday that there is an acute shortage of tracheostomy tubes, including Bivona tracheostomy tubes manufactured by healthcare supplier ICU Medical ( NASDAQ: ICUI ). The agency said that the shortage of Bivona tracheost...
SAN CLEMENTE, Calif., Oct. 06, 2022 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced the time of its third quarter 2022 earnings release and conference call. The Company will release ...
SAN CLEMENTE, Calif., Sept. 08, 2022 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced that Company management will participate in a fireside chat at the Morgan Stanley Annual Global Healthc...
ICU Medical has fallen well short of expectations for its first year with Smiths Medical in the fold, as the acquired operations have needed considerable work to address operational issues. Core ICU Medical operations are performing reasonably well, with mid-single-digit growth in the...
ICU Medical, Inc. (ICUI) Q2 2022 Earnings Conference Call August 8, 2022, 4:30 PM ET Company Participants John Mills - ICR Vivek Jain - CEO & Chairman Brian Bonnell - CFO & Treasurer Conference Call Participants Jayson Bedford - Raymond James ...
News, Short Squeeze, Breakout and More Instantly...
SAN CLEMENTE, Calif., July 24, 2024 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq: ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced the time of its second quarter 2024 earnings release and conference call. The Company will release its ...
SAN CLEMENTE, Calif., May 07, 2024 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced financial results for the quarterly period ended March 31, 2024. First Quarter 2024 Results First...
Aterian Inc. (ATER) is expected to report for Q1 2024 Dorman Products Inc. (DORM) is expected to report $0.82 for Q1 2024 Hillman Solutions Corp. (HLMN) is expected to report $0.08 for Q1 2024 Wake Forest Bancshares, Inc. (WAKE) is expected to report for quarter end 2024-03-31 Inn...